source
- Be Bio halts hemophilia B cell-editing therapy trialBe Bio announced that it has terminated its clinical study of a hemophilia B therapy that used gene-editing of a patient’s own cells. The termination was recorded in a federal clinical-trials regi…
- OpenLoop Health says it can launch a virtual GLP-1 prescribing service in 24 hoursOpenLoop Health says it can set up a telehealth operation that can prescribe GLP-1 medicines within a day. The company provides the medical‑group infrastructure that powers multiple virtual care p…